A better buy-in window may exist right now for Catalyst Pharmaceuticals Inc (CPRX)

With 1.06 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.25 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $24.6464 whereas the lowest price it dropped to was $23.81. The 52-week range on CPRX shows […]

Prepare Yourself for Liftoff: Catalyst Pharmaceuticals Inc (CPRX)

With 0.85 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.27 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $23.52 whereas the lowest price it dropped to was $23.0. The 52-week range on CPRX shows […]

Does Catalyst Pharmaceuticals Inc (CPRX) offer a good opportunity for investors?

With 1.09 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.35 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $23.1277 whereas the lowest price it dropped to was $21.95. The 52-week range on CPRX shows […]

Nothing is Better Than Catalyst Pharmaceuticals Inc (CPRX) stock at the moment

With 1.48 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.32 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $25.96 whereas the lowest price it dropped to was $25.02. The 52-week range on CPRX shows […]

Adversity is less terrifying than hope: Catalyst Pharmaceuticals Inc (CPRX)

With 0.99 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.13 million shares. The 52-week range on CPRX shows that it touched its highest point at $24.64 and its lowest point at $14.47 during that stretch. It currently has a 1-year price target of $33.62. Beta for […]